Explore more about: COVID-19

Share:

EmailFacebookLinkedInXWhatsAppShare
News
A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.
News
NIH has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 diagnostics.
News
A new study that could have immediate implications for COVID-19 testing in schools found that with age-appropriate instructions, school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen.
News
Researchers funded by NIH's RADx Tech program have developed a fast, cost-effective method to detect the circulation of SARS-CoV-2 variants. The team adopted a customizable genotyping approach to identify known variants and subvariants—an approach that can augment current surveillance.
News

After less than two years of data collection and processing, RSNA has successfully delivered over 30,000 de-identified imaging studies to the Medical Imaging and Data Resource Center (MIDRC) project, an open-access platform which publishes data to be used for research. MIDRC is funded by NIBIB. Source: RSNA News

News
A new type of COVID-19 test is hitting the market, and could change how we detect the virus. MicroGEM, a Virginia-based molecular biology company with a Charlottesville office, is using its new saliva test to track COVID-19. Source: NBC TV12 Richmond, Virginia.
News
Two recent studies supported by the National Institutes of Health Rapid Acceleration of Diagnostics (RADx) Tech program demonstrate how widespread distribution of COVID-19 at-home antigen tests can be used as an effective public health strategy to reduce the spread of the disease. Source: UMass Chan
News
A new rapid PCR COVID-19 test invented by Northwestern University faculty and Minute Molecular Diagnostics has received FDA emergency use authorization.
News
A small preliminary study from Northwestern Medicine has shown that a blood test may identify risk of stillbirth and placentitis in pregnant individuals who have had COVID-19. The finding builds on another study with similar results and could have implications in how physicians screen for and address high-risk pregnancies.
News
NIBIB grantee Wilbur Lam was quoted in this Washington Post article about the ‘test to treat’ COVID-19 plan. Lam leads the Atlanta Center for Microsystems Engineered POC Tech at Emory University, which has been evaluating COVID-19 tests for RADx®.